Log in

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56
  1. A global review of COVID-19 impact on cancer treatment and research (0 replies)
  2. Study finds severe financial distress among breast cancer survivors (0 replies)
  3. ACGT awards $500,000 grant to advance strategies for treating solid tumors (0 replies)
  4. Researchers develop new testing platform for breast cancer cells (0 replies)
  5. Research indicates increased breast cancer mortality in African American and Black su (0 replies)
  6. New tools to enhance care for brain metastases (0 replies)
  7. Applying the power of AI to improve heart-transplant outcomes (0 replies)
  8. Study: Radiotherapy and surgery offer better protection in treating abnormal breast t (0 replies)
  9. Women with benign breast conditions can undergo surgery without affecting their abili (0 replies)
  10. New findings clarify the long-term risks for women with DCIS (0 replies)
  11. Study offers the standard of surgical care for early-stage breast cancer (0 replies)
  12. Researchers receive NCI grant to study role of collagens in breast cancer (0 replies)
  13. Researchers identify a potential target for small cell lung cancer (0 replies)
  14. Study shows effects of COVID-19 pandemic on breast cancer screening (0 replies)
  15. Patients with invasive lobular carcinoma could benefit from additional adjuvant thera (0 replies)
  16. Study finds link between beta-blockers and survival outcomes in some breast cancer pa (0 replies)
  17. COVID-19-related interruptions in rehabilitation care causes emotional distress in br (0 replies)
  18. New approach uses AI to identify which early stage breast cancers will spread (0 replies)
  19. Researchers use natural pigment for screening cell viability (0 replies)
  20. Lack of considerations in cumulative effect of food chemicals could have contributed (0 replies)
  21. Researchers develop 'Trojan horse' approach to destroy cancer cells (0 replies)
  22. Researchers identify genetic markers linked to higher risk of capecitabine-induced ha (0 replies)
  23. Black breast cancer patients experience more delays in treatment initiation, duration (0 replies)
  24. Black women experience longer waits for treatment after breast cancer diagnosis, indi (0 replies)
  25. Adding abemaciclib to hormonal therapy reduces recurrence in patients with HR+ HER2- (0 replies)
  26. Cellular recyclers could be used to eliminate the driver of cancer's aggressiveness (0 replies)
  27. PPI use linked to worse outcomes in urothelial cancer patients treated with atezolizu (0 replies)
  28. PET/MRI reduces radiation exposure, improves lesion detectability in select cancers (0 replies)
  29. Sub-Saharan Africa needs greater access to live-saving antibodies (0 replies)
  30. Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer (0 replies)
  31. Researchers receive $2.5 million grant to develop and analyze breast tumor organoids (0 replies)
  32. UofL receives $11.5 million to accelerate the development of new immunotherapies (0 replies)
  33. Simple blood tests can benefit women with breast cancer (0 replies)
  34. A novel gene involved in primary lymphedema identified (0 replies)
  35. Brazilian red propolis contains substances with anti-cancer properties (0 replies)
  36. New method could advance efforts to find drugs that kill breast cancer cells (0 replies)
  37. Study uncovers genetic vulnerability in breast cancers tumors (0 replies)
  38. Spironolactone may be safe to treat female pattern hair loss in breast cancer survivo (0 replies)
  39. Novel drug could improve life expectancy and quality for patients with hard-to-treat (0 replies)
  40. New drug can enhance life expectancy and quality for patients with hard-to-treat canc (0 replies)
  41. Newly discovered mechanism may lead to better treatment options for breast cancer (0 replies)
  42. Environmental and biomedical applications of enzyme inhibitors (0 replies)
  43. Researchers aim to improve digital thermal imaging as a tool for monitoring cancer (0 replies)
  44. Lack of oxygen can trigger tumor metastases (0 replies)
  45. Renowned Harley Street hospital performs pioneering dual breast surgery (0 replies)
  46. Novel markers may predict patient response to immune checkpoint inhibitors (0 replies)
  47. Exploring alternative diagnosis options for women with deep infiltrating endometriosi (0 replies)
  48. Mason researchers to provide biostatistics and bioinformatic analysis for new project (0 replies)
  49. Study explores link between personal use of hair dyes and cancer risk (0 replies)
  50. Why Black aging matters, too (0 replies)
  51. Honeybee venom induces cancer cell death in aggressive breast cancer (0 replies)
  52. Study reveals the unexpected benefits of telehealth services (0 replies)
  53. Study: BIRC2 overexpression could be a key marker for immunotherapy resistance (0 replies)
  54. Cancer cells reshape, destroy or integrate into blood vessels to spread (0 replies)
  55. Growth hormone associated with early puberty and future breast cancer risk (0 replies)
  56. Honeybee venom rapidly destroys aggressive breast cancer cells (0 replies)
  57. Virginia Tech researcher wins NIH award to study possible treatments for metastatic b (0 replies)
  58. Prosthetic breast reconstruction outcomes do not deteriorate over time, shows study (0 replies)
  59. Manipulating 3D Printed Organoid Microenvironments (0 replies)
  60. New breast cancer drug is safe and effective, can halt disease progression (0 replies)
  61. AI algorithm proves to be as accurate as average radiologist in identifying breast ca (0 replies)
  62. Research identifies protein molecule that could be responsible for aggressive breast (0 replies)
  63. Scientists combine 3D bioprinting and computer modeling to study cancer metastasis in (0 replies)
  64. Premenopausal women previously treated with radiation have worse breast cancer-specif (0 replies)
  65. Tumor hierarchy of breast cancer cells can be potential cause for drug resistance (0 replies)
  66. Blood cancer patients are more vulnerable to the effects of COVID-19, study finds (0 replies)
  67. Women with T1a breast cancers could benefit from hormone treatment (0 replies)
  68. New surgical approach is highly acceptable among women with ovarian cancer risk (0 replies)
  69. Developing more precise, targeted therapy for a highly aggressive breast cancer (0 replies)
  70. Key molecule can be used to assess prognosis of triple negative breast cancer (0 replies)
  71. FDA provides update on adverse events associated with breast implants (0 replies)
  72. Scientists reveal why genetic background influences disease risk from single-gene var (0 replies)
  73. New database could speed the development of gene-targeted therapies for breast cancer (0 replies)
  74. COVID-19 pandemic delays care for half of breast cancer survivors (0 replies)
  75. Study considers strategies used for multidisciplinary breast cancer management during (0 replies)
  76. New test could help predict survival of women with ovarian cancer (0 replies)
  77. Using music therapy to combat 'chemobrain' (0 replies)
  78. Smartphones could be used to detect Type 2 diabetes (0 replies)
  79. New type of immunotherapy extends survival of mice with triple negative breast tumors (0 replies)
  80. Back to life: COVID lung transplant survivor tells her story (0 replies)
  81. Tiny packages of materials released by tumors may serve as biomarkers for detecting c (0 replies)
  82. Study: Screening women aged 40-49 reduces breast cancer mortality (0 replies)
  83. Researchers review scientific articles on proteins that help cancer cells enter the b (0 replies)
  84. Study identifies factors that influence women's decisions regarding therapy options (0 replies)
  85. Mouse study shows potential new way to unlock the power of immunotherapy for cancer p (0 replies)
  86. Study shows how African health services are handling disruptions caused by COVID-19 (0 replies)
  87. Oxygen-deprived breast cancer cells send out messages that promote cancer progression (0 replies)
  88. Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM (0 replies)
  89. DCIS surgical delays do not impact overall survival, shows study (0 replies)
  90. Surgical delay does not lower overall survival of women with early-stage breast cance (0 replies)
  91. Gene could predict treatment response in certain breast cancer patients (0 replies)
  92. HDAC6 inhibitors increase efficacy of immunotherapy in triple-negative breast cancer (0 replies)
  93. New automated cytometry test for rapid point-of-care cancer diagnosis (0 replies)
  94. Existing drug used to treat alcoholism is potentially effective against COVID-19 (0 replies)
  95. Novel technology tests the presence of thin membrane protrusions on breast cancer cel (0 replies)
  96. NCI gives 'exceptional' rating to Penn's Abramson Cancer Center (0 replies)
  97. Researchers identify two dozen pesticides linked with mammary gland tumors (0 replies)
  98. Russian researchers suggest device to improve breast MRI (0 replies)
  99. Researchers to test the effectiveness of intervention that addresses barriers to brea (0 replies)
  100. Avoiding care during the pandemic could mean life or death (0 replies)
  101. Research shows Imagion nanoparticles enable low-field MRI (0 replies)
  102. Research assesses the prevalence of overscreening for cancers among older adults (0 replies)
  103. Investigational vaccine and immune therapy work well together to fight breast cancer (0 replies)
  104. Patent issued for Concarlo-developed therapeutic peptide to treat drug-resistant brea (0 replies)
  105. Social distancing in the United States varies strongly by income (0 replies)
  106. Stand Up To Cancer announces $1.1 million in funding to foster collaborative research (0 replies)
  107. Study identifies women who benefit less from digital breast tomosynthesis (0 replies)
  108. Study reveals new mechanism that that fuels cancer adaptation (0 replies)
  109. Cancer-related care has decreased since the start of COVID-19 (0 replies)
  110. Researchers identify new genetic tool that can help treat certain cancers (0 replies)
  111. Reducing the incidence of drug-induced interstitial lung disease in breast cancer pat (0 replies)
  112. Study reveals global trends in premenopausal and postmenopausal breast cancer (0 replies)
  113. Study shows interferons do not induce the expression of SARS-CoV-2 cell entry recepto (0 replies)
  114. Eikonoklastes Therapeutics announces closing of oversubscribed seed financing (0 replies)
  115. Study finds viable drug target for triple negative breast cancer (0 replies)
  116. JRC releases 2020 estimates on cancer burden in the EU (0 replies)
  117. SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of (0 replies)
  118. Immunotherapeutic intervention to reduce stress prevents tumor metastases (0 replies)
  119. Cancer diagnostic capacity should be ramped up to avoid unnecessary deaths, say resea (0 replies)
  120. Fasting-mimicking diet along with hormone therapy could help treat breast cancer (0 replies)
  121. Proximity of mutated cells guides the initiation of tumor (0 replies)
  122. Researchers develop new nano drug that kills triple-negative breast cancer cells (0 replies)
  123. Groundbreaking technology could enhance therapeutic efficiency of nanomedicines (0 replies)
  124. Rare inherited mutation in TP53 gene confers risk of multiple cancers (0 replies)
  125. Novel method for selecting the best drug therapy for cancer (0 replies)
  126. Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors (0 replies)
  127. Innovative system aims to improve predictions of survival indicators in breast cancer (0 replies)
  128. Upcoming phase II study to discover personalized therapy for patients at high risk fo (0 replies)
  129. Expansion stress promotes aggressive tumor cell growth in breast cancer (0 replies)
  130. Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer t (0 replies)
  131. Breast cancer cells can reprogram natural killer cells to aid in metastasis (0 replies)
  132. Breast cancer simulation models can guide screening recommendations for women (0 replies)
  133. Aspirin and flavonoids in fruits and vegetables could help prevent colorectal cancer (0 replies)
  134. Coronary calcium scoring can help doctors make the right recommendation about statin (0 replies)
  135. New assay uses unique fluorescent tags to analyze multiple cell populations (0 replies)
  136. Moffitt researchers discover key protein involved in cancer metastasis (0 replies)
  137. Fertility can be successfully preserved in breast cancer patients, shows study (0 replies)
  138. Using machine learning to analyze the interaction of breast cancer risk factors (0 replies)
  139. Common chemotherapy drug may be less effective in overweight, obese breast cancer pat (0 replies)
  140. Tele-med.ai: New information resource launched by Center for Diagnostics and Telemedi (0 replies)
  141. New technology can increase the quality of stem cells used in regenerative medicine (0 replies)
  142. Women with breast cancer diagnosed at earlier stage in states with expanded Medicaid (0 replies)
  143. Researchers to receive Real-World Data Impact Award to advance patient-centric resear (0 replies)
  144. Research shows how a protein's small change leads to big trouble for cells (0 replies)
  145. Research shows IQGAP1 as a common target in variants of triple negative breast cancer (0 replies)
  146. Glowing dye may illuminate tumors during surgery (0 replies)
  147. New method for analyzing intact tumor samples to be used for studying COVID-19 (0 replies)
  148. Enhanced photoacoustic imaging improves cancer staging (0 replies)
  149. New steroid compounds from deep-water starfish show anticancer activity (0 replies)
  150. Study may provide opportunities to improve diet quality among cancer survivors (0 replies)
  151. Certain genes that predispose to cancer also affect the immune system, study shows (0 replies)
  152. Fearing the deadly combo of COVID-19 and cancer (0 replies)
  153. Researchers develop a noninvasive technology to destroy cancer cells (0 replies)
  154. Tau protein modifications may be linked to heterogeneity in Alzheimer’s disease (0 replies)
  155. A new approach to track down cryptic peptides (0 replies)
  156. Research reveals new insights into molecular circuitry controlling cancer growth and (0 replies)
  157. Improving cancer therapies by exploiting drug resistance in cancer (0 replies)
  158. Innovative use of focused ultrasound shows promise against glioblastoma (0 replies)
  159. New technology detects breast cancer using tears (0 replies)
  160. Researchers caution use of chloroquine therapy for patients at higher risk of heart r (0 replies)
  161. Novel biomarkers required to triage and monitor severely ill COVID-19 patients (0 replies)
  162. USC researchers unlock fatal vulnerability in many cancer cells (0 replies)
  163. Two potent small molecules appear to suppress tumor growth in multiple cancers (0 replies)
  164. Common cholesterol drugs could slow breast cancer metastasis to the brain (0 replies)
  165. Accelerating the Diagnosis and Treatment of Cancer with Mass-Spectrometry Based Techn (0 replies)
  166. Study reveals protein responsible for vulnerability in cancer cells (0 replies)
  167. Study finds link between high levels of dietary AGEs and breast cancer risk (0 replies)
  168. RCSI scientists develop new biomaterial with potential to accelerate bone regeneratio (0 replies)
  169. Rice lab's fluorescent tag project reveals new method to kill tumors (0 replies)
  170. Scientists develop new test to help identify people at risk for developing liver canc (0 replies)
  171. Artificial intelligence, probabilistic modeling can improve prediction of survival in (0 replies)
  172. Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer stu (0 replies)
  173. New protocol to deliver optimal care for breastfeeding women with breast cancer (0 replies)
  174. Key recommendations on genetic testing of men for prostate cancer (0 replies)
  175. Studies show prognostic value for circulating tumor cells in advanced prostate and br (0 replies)
  176. Study: Breast cancer reduction efforts show mixed progress (0 replies)
  177. New insights on DNA replication can help develop novel cancer treatments (0 replies)
  178. New diet and physical activity guideline to prevent cancer (0 replies)
  179. Innovative algorithm helps select patients in need of urgent surgery or chemotherapy (0 replies)
  180. Newer data confirms survival advantages, but also side effects for ribociclib in brea (0 replies)
  181. Study investigates combined effects of cancer therapy and inherited genetics (0 replies)
  182. Researchers discover novel gene involved in DNA damage repair and male fertility (0 replies)
  183. New consensus on how cancer clinical trial stakeholders can best interact on social p (0 replies)
  184. Study explores the role of mi RNAs in anticancer effect exerted by physical activity (0 replies)
  185. Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockad (0 replies)
  186. Tumors cause disruption of the immune system throughout the body, study finds (0 replies)
  187. ‘Terminator’ protein suppresses tumorigenesis (0 replies)
  188. Researchers examine the role of two genes that cause triple-negative breast cancer (0 replies)
  189. Rigidity of tissues drives immune system activity, UCLA study finds (0 replies)
  190. Bacteria lurking in cancer cells may affect treatment (0 replies)
  191. A satisfying romantic relationship predicts lower stress, inflammation in breast canc (0 replies)
  192. Fraunhofer researchers investigate the mechanisms of metastasis formation (0 replies)
  193. Update on PALLAS triaI evaluating adjuvant palbociclib for early breast cancer (0 replies)
  194. Cancer clusters' resistance to natural killer cell immunosurveillance favors metastas (0 replies)
  195. A moving target identified in small cell lung tumors (0 replies)
  196. Monoclonal antibody therapy achieves modest reduction in recurrence for patients with (0 replies)
  197. Using gene therapy to help the body to make its own cancer drugs (0 replies)
  198. Radiation and surgery do not prolong survival in newly diagnosed metastatic breast ca (0 replies)
  199. Ludwig Cancer Research study profiles immune landscape of brain tumors (0 replies)
  200. Targeted drugs shrink breast cancer tumors in mice without toxic side effects (0 replies)
  201. A promising method for treating triple-negative breast cancer (0 replies)
  202. Findings provide new insights into future cancer treatment (0 replies)
  203. Researchers investigate the early development of ovarian cancer (0 replies)
  204. Antimalarial drug shows promise as potential therapy for aggressive brain cancer (0 replies)
  205. RCSI and LEO Pharma team up to investigate the role of blood clotting protein in brea (0 replies)
  206. Researchers identify genetic mechanisms that produce radioresistance in cancer cells (0 replies)
  207. Free app helps assess the risk of delaying cancer care during COVID-19 (0 replies)
  208. Scientists discover how an obscure protein promotes breast cancer progression (0 replies)
  209. New therapeutic approach for aggressive breast cancer (0 replies)
  210. Supportive care for reducing fatigue may not be sufficiently adhered to by breast can (0 replies)
  211. Platinum-based chemotherapy may improve outcomes for some metastatic pancreatic cance (0 replies)
  212. Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast (0 replies)
  213. Breast cancer survivors underutilize supportive care to relieve cancer-related fatigu (0 replies)
  214. New follow-up care models could benefit thousands of cancer survivors (0 replies)
  215. Scientists create a detailed map of how carcinogens trigger breast cancer development (0 replies)
  216. Just a little physical activity can have big impact for women with high-risk breast c (0 replies)
  217. Research looks at COVID-19 in cancer patients (0 replies)
  218. Understanding why pancreatic ductal adenocarcinoma is so aggressive (0 replies)
  219. Hop supplements used by menopausal women are not likely to cause drug interactions (0 replies)
  220. SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program (0 replies)
  221. Researchers identify determining factor in luminal cancer cells (0 replies)
  222. New analysis links DNA variations to risks of specific breast cancer subtypes (0 replies)
  223. Cancer biologists identify important drivers of tumor resistance (0 replies)
  224. Interdisciplinary team to develop a new physics-based technology for COVID-19 detecti (0 replies)
  225. New book demystifies the molecular biology of breast cancer (0 replies)
  226. Study shows the combined effect of inherited and acquired mutations on cancer develop (0 replies)
  227. High DPP3 concentration in the blood predicts multiple organ failure in burn patients (0 replies)
  228. Text reminders are not a silver bullet to improve breast cancer hormone therapy adher (0 replies)
  229. Researchers identify new breast cancer gene in young women (0 replies)
  230. Study refutes link between anti-hormonal breast cancer therapy and rheumatoid arthrit (0 replies)
  231. Mammogram screening and high fiber diet help combat breast cancer (0 replies)
  232. Fasting-mimicking diet plus vitamin C could be effective at treating some cancer type (0 replies)
  233. New discovery may contribute to early identification of aggressive breast tumors (0 replies)
  234. Researchers report decline in cancer diagnoses due to COVID-19 crisis (0 replies)
  235. Study reveals the effect of ancestry on molecular makeup of cancer (0 replies)
  236. Indiana researchers identify new target for colorectal cancer immunotherapy (0 replies)
  237. Common allergy medicine may improve survival in patients with malignant melanoma (0 replies)
  238. Mammography screening reduces rates of advanced and fatal breast cancers (0 replies)
  239. The nutritional key to control autoimmunity and cancer (0 replies)
  240. Novel anti-cancer medicine could improve current therapy for ER+ breast cancer (0 replies)
  241. Immune checkpoint inhibition led to clinical responses in patients with advanced mela (0 replies)
  242. Researchers show basic lymphatic vessel functionality is the same in mice and humans (0 replies)
  243. Cancer patients with COVID-19 more likely to die from the disease (0 replies)
  244. Breakthrough study shows liquid biopsy test can safely detect 26 undiagnosed cancers (0 replies)
  245. Immunotherapy before surgery may help eradicate high-risk breast cancer (0 replies)
  246. Discovery of new type of immune cell in breast ducts (0 replies)
  247. Simple blood test offers early warning of chemotherapy-related cardiac dysfunction (0 replies)
  248. Talazoparib did not show overall survival benefit in patients with advanced BRCA-muta (0 replies)
  249. AMPK activation by anti-diabetes drug promotes survival of dormant breast cancer cell (1 replies)
  250. Prostate cancer mortality rates predicted to fall in the EU but rise in Poland (0 replies)